These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6313322)

  • 1. Peripheral nerve damage in epileptic patients treated with phenytoin.
    Bahemuka M; Wainaina CM
    East Afr Med J; 1983 Jan; 60(1):26-9. PubMed ID: 6313322
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral neuropathy in long-term diphenylhydantoin therapy.
    Lovelace RE; Horwitz SJ
    Trans Am Neurol Assoc; 1967; 92():262-4. PubMed ID: 4329415
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral neuropathy in epileptics.
    Neurology; 1982 Apr; 32(4):457-8. PubMed ID: 6278366
    [No Abstract]   [Full Text] [Related]  

  • 4. Motor nerve conduction study in patients on diphenylhydantoin therapy.
    Chokroverty S; Sayeed ZA
    J Neurol Neurosurg Psychiatry; 1975 Dec; 38(12):1235-9. PubMed ID: 176326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral nerve function in patients with long-term anticonvulsant therapy (author's transl)].
    Fujiwara T; Seko K; Akiguchi I; Yamada N; Iwai N
    Rinsho Shinkeigaku; 1979 Nov; 19(11):735-43. PubMed ID: 535298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemostasis in epileptic patients treated with anticonvulsant drugs].
    de Pasquet EG; Ghiggino CW; Toledo S; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):67-77. PubMed ID: 4808368
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral neuropathy in epileptic patients.
    Swift TR; Gross JA; Ward LC; Crout BO
    Neurology; 1981 Jul; 31(7):826-31. PubMed ID: 6264351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysis.
    Kaul A; Goyle S
    Teratog Carcinog Mutagen; 1999; 19(1):61-72. PubMed ID: 10321411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hygiene status of epileptic patients under treatment with diphenyl hydantoin.
    Codipilly DP; Hoover JN
    Odontostomatol Trop; 1983 Dec; 6(4):223-7. PubMed ID: 6588372
    [No Abstract]   [Full Text] [Related]  

  • 10. Nerve conduction velocity in patients on long-term diphenylhydantoin therapy.
    Encinoza O
    Epilepsia; 1974 Jun; 15(2):147-54. PubMed ID: 4365396
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydantoins and neurologic complications].
    Rohmer F; Collard M; Warter JM; Coquillat G
    Nouv Presse Med; 1973 Feb; 2(8):513. PubMed ID: 4347603
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral neuropathy in children on long-term phenytoin therapy.
    Mochizuki Y; Suyehiro Y; Tanizawa A; Ohkubo H; Motomura T
    Brain Dev; 1981; 3(4):375-83. PubMed ID: 6274215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and electrophysiologic evaluation of peripheral nerve function in chronic phenytoin therapy.
    Taylor JW; Murphy MJ; Rivey MP
    Epilepsia; 1985; 26(5):416-20. PubMed ID: 2995024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of antiepileptic drugs: a peripheral neuropathy due to diphenylhydantoin (DPH) intoxication.
    Uchigata M; Nozawa T; Shiozawa R; Tanabe H
    Folia Psychiatr Neurol Jpn; 1980; 34(3):314-5. PubMed ID: 6260604
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible subacute peripheral neuropathy induced by phenytoin.
    Dobkin BH
    Arch Neurol; 1977 Mar; 34(3):189-90. PubMed ID: 190987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy in long-term diphenylhydantoin therapy.
    Lovelace RE; Horwitz SJ
    Arch Neurol; 1968 Jan; 18(1):69-77. PubMed ID: 4293820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurologic complications following medical treatment of epileptic patients].
    Boldyrev AI; Fleĭs EP; Vaĭntrub MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(6):738-41. PubMed ID: 224628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.